feed
view company updates
tools
perform investment research
network
join events & discussions
advisory
about us
Redeye Capital
Xbrane Biopharma: Mindre försening ökar risken kring kassan
Research Note
2020-02-28
09:13
Xbrane rapporterade under morgonen för fjärde kvartalet, vi ger en kort kommentar kring detta.
JS
Jakob Svensson
Sign up for free to continue
Sign up with Email
Sign in with Google
Already a member?
Sign in
Disclosures and disclaimers
Premium Plan required to unlock
Unlock companies to access
more high quality research.
View Plans